The invention relates to the use of compounds having both dopamine D2-antagonistic activity and serotonin reuptake inhibitory (SRI) activity for the treatment of psychotic disorders such as schizophrenia. The invention further relates to a group of novel (1, 2, 3,6-tetrahydropyridin-4-yl) indole and -furan derivatives having these activities.
申请公布号
WO0069424(A3)
申请公布日期
2001.06.07
申请号
WO2000EP03506
申请日期
2000.04.14
申请人
SOLVAY PHARMACEUTICALS B.V.;VAN HES, ROELOF;VAN DER HEIJDEN, JOHANNES, A., M.;KRUSE, CORNELIS, G.;LONG, STEPHEN, K.
发明人
VAN HES, ROELOF;VAN DER HEIJDEN, JOHANNES, A., M.;KRUSE, CORNELIS, G.;LONG, STEPHEN, K.
